Comparing Reports Recorded by the Patients at the Time at Which They Feels Pain to What Patients Report at Monthly Visits to Assess Symptoms of Musculoskeletal Diseases.
The Importance of Ecological Momentary Assessment to Capture the Whole Patient's Symptoms Experience in Musculo-skeletal Conditions
1 other identifier
observational
1,500
2 countries
2
Brief Summary
Patients will be introduced to the use of a mobile application for their smartphone to record the Ecological Momentary Assessment (EMA). This app will ask the patients to assess their pain and function two times daily for 2 months. After 1 month and at the end of the 2 months, follow-up visits will be performed and patients will be asked to retrospectively evaluate the pain that they suffered and the level of function they had during the last month.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2021
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 6, 2021
CompletedFirst Submitted
Initial submission to the registry
February 22, 2024
CompletedFirst Posted
Study publicly available on registry
February 28, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
August 6, 2025
February 1, 2025
6.7 years
February 22, 2024
August 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in pain level
difference between the level of pain collected within the first month of mobile application and the level of pain reported through a retrospective recall-based assessment on the 0-10 Numerical Rating Scale
one month
Eligibility Criteria
patients with musculoskeletal chronic pain with a clinical and imaging diagnosis of an orthopaedic disease such as knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, ankle osteoarthritis, rizoathrosis, meniscectomy treatment, rotator cuff tendinopathy, low-back pain, Achille tendinopathy, patellar tendinopathy,and tennis elbow.
You may qualify if:
- Symptomatic patients
- Patients able to give informed consent and to follow the protocol of the study (i.e. able to use a smartphone)
- Patients \>18 years
- BMI \<35 and \>18.5
- Patients with a smartphone with Android or iOS as operative systems
You may not qualify if:
- Patients unable to follow the protocol of the study (i.e. unable to use a smartphone, not owning a smartphone or unwilling to download or use the application)
- Patients with a diagnosis of a musculoskeletal injury but without symptoms
- Patients without a radiological examination confirming the diagnosis of musculoskeletal disease
- Patients with planned surgery in the following 60 days
- Pregnant or lactating woman
- Patients with other diseases causing pain in the involved joint (e.g. rheumatoid arthritis or other rheumatologic diseases).
- Surgical treatment in the last year and intra-articular injection in the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
IRCCS Istituto Ortopedico Rizzoli
Bologna, Italy
EOC - Orthopaedics and Traumatology Service
Lugano, 6900, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2024
First Posted
February 28, 2024
Study Start
April 6, 2021
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
August 6, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share